Background The optimal duration of oral anticoagulant therapy after a first episode of venous
thromboembolism is still a matter of debate. Methods We performed a multicenter trial …

Background Both chronic obstructive pulmonary disease (COPD) and tuberculosis (TB)
primarily affect the lungs and are major causes of morbidity and mortality worldwide. COPD and …

Objectives. —To describe prevention activities and risk behavior in cities where human
immunodeficiency virus (HIV) was introduced into the local population of injecting drug users (…

Objective To investigate whether a Medication Report can reduce the number of medication
errors when elderly patients are discharged from hospital. Method We conducted a …

Objectives. To study the rates of elimination of total prostate-specific antigen (PSA-T), free
PSA (PSA-F), and PSA complexed to alpha 1 -antichymotrypsin (PSA-ACT) from blood after …

Iohexol, a newly developed non-ionic contrast agent, has been recently documented as a
reliable glomerular filtration marker. This study describes the age dependence of the single …

Chronic pulmonary disease is a recognized risk factor for invasive pneumococcal disease (IPD).
However, previous studies have often not been large enough to allow detailed analyses …

The length of time for which deep vein thrombosis (DVT) should be treated with oral anticoagulants
(OA) is controversial. In this study, 135 patients with symptomatic first period DVT (83 …

Exchange of syringes and needles has for the last 3 years been offered to injecting drug
users as part of an HIV prevention project in a small university town in south Sweden. The …

In an ongoing health‐technology assessment of haemophilia treatment in Sweden, performed
by the governmental agency Dental and Pharmaceutical Benefits Agency (TLV; tandvards…